Joint Intensive Care 60 Tablets

Joint Intensive Care 60 Tablets is a practitioner-grade formula from Metagenics, New Zealand's trusted evidence-based supplement brand, designed to support mild joint pain. The product's new name reflects its evolution from Inflavonoid Intensive Care and it remains vegan, offered in a 60-tablet pack.

• Product name and lineage: NEW NAME: Joint Intensive Care (formerly Inflavonoid Intensive Care)
• Brand and origin: Metagenics, New Zealand
• Formulation: Practitioner-grade, vegan
• Quantity: 60 tablets per pack
• Primary benefit: Supports mild joint pain and inflammation
• Usage guidance: Always read the label and use only as directed; if symptoms persist, consult a healthcare professional

Designed for individuals seeking plant-based support for mild joint discomfort, Joint Intensive Care leverages Metagenics' evidence-based approach to nutrition. The vegan formulation aligns with dietary preferences while providing a concise, 60-tablet supply intended for ongoing use. By supporting joint comfort and managing occasional inflammation, it can help ease daily activities and promote a more comfortable range of motion. Consider adding Joint Intensive Care to your routine and discuss suitability with your healthcare professional.

Frequently asked questions

• What is Joint Intensive Care 60 Tablets? A practitioner-grade vegan supplement from Metagenics designed to support mild joint pain and occasional inflammation.
• Is this product vegan? Yes, the formulation is vegan.
• How many tablets are included per pack? Each pack contains 60 tablets. Follow the label for dosage and directions.